GWOX yields 7.20% · JNJ yields 2.13%● Live data
📍 GWOX pulled ahead of the other in Year 1
Combined, GWOX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GWOX + JNJ for your $10,000?
The Goodheart-Willcox Company, Inc. publishes print and digital textbooks. It also produces online courses and other instructional resources for middle school, high school, higher education, and professional training. The company publishes books in the areas of anatomy/physiology, FCS comprehensive, journalism, applied mathematics, FCS family living, life management, automotive, finance, manufacturing/metals, CAD/drafting, floral design, marketing, career education, food/nutrition, print reading, child care/human development/parenting, health, professional, clothing and fashion, health sciences, software certification, communication, hospitality, technology/engineering, construction, HVAC-R, video game design, culinary arts, information technology, visual technology, electricity/electronics, interior design/housing, and welding. In addition, it offers online textbooks, G-W online courses, companion Websites, and CourseSmart eTextbooks. The Goodheart-Willcox Company, Inc. was founded in 1921 and is based in Tinley Park, Illinois.
Full GWOX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.